Biotechnology - Genomic and Proteomics/IP Profile of Biggest for-profit companies in BGP/BGP Company Profiles - Data: Difference between revisions
Jump to navigation
Jump to search
(→Amgen) |
(→What) |
||
| Line 6: | Line 6: | ||
===Who=== | ===Who=== | ||
===What=== | ===What=== | ||
* ten approved drugs for 15 conditions, 23 agents are being tested earlier in the approval pipeline | |||
===Where=== | ===Where=== | ||
===News=== | ===News=== | ||
Revision as of 21:35, 6 April 2009
NIH
Celera
Amgen
Who
What
- ten approved drugs for 15 conditions, 23 agents are being tested earlier in the approval pipeline
Where
News
Commons-Based, Peer-Production, and Open Access News
Genentech
Genzyme
Gilead Sciences
Biogen Idec
Cephalon
MedImmune
Celgene
Abraxis BioScience
ImClone Systems
IP Profile of Biggest for-profit companies in BGP